Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant ...
Explore how Epstein-Barr may link to multiple sclerosis, affecting nearly one million people in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results